Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Ricca

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 4, 2022
A novel bone registration method using impression molding and structured-light 3D scanning technologyGuangyu He, Jacob M Ricca, Amos Z Dai, et al.
The Journal of Clinical Investigation|March 6, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
The Journal of Clinical Investigation|October 3, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
Science Immunology|August 2, 2017
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cellsPeihong Dai, Weiyi Wang, Ning Yang, et al.
Cellular Immunology|June 18, 2013
A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitroSamantha A Chalmers, Alec S Eidelman, Jason C Ewer, et al.
Oncotarget|July 10, 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virusAnton Oseledchyk, Jacob M Ricca, Mathieu Gigoux, et al.
Breast Cancer : Basic and Clinical Research|November 5, 2016
A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary CarcinomaMary J Higgins, Antonio Serrano, Kofi Y Boateng, et al.
Cell|March 31, 2023
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variantsDaniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|February 4, 2022
A novel bone registration method using impression molding and structured-light 3D scanning technologyGuangyu He, Jacob M Ricca, Amos Z Dai, et al.
The Journal of Clinical Investigation|March 6, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
The Journal of Clinical Investigation|October 3, 2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapyDmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, et al.
Science Immunology|August 2, 2017
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cellsPeihong Dai, Weiyi Wang, Ning Yang, et al.
Cellular Immunology|June 18, 2013
A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitroSamantha A Chalmers, Alec S Eidelman, Jason C Ewer, et al.
Oncotarget|July 10, 2018
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virusAnton Oseledchyk, Jacob M Ricca, Mathieu Gigoux, et al.
Breast Cancer : Basic and Clinical Research|November 5, 2016
A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary CarcinomaMary J Higgins, Antonio Serrano, Kofi Y Boateng, et al.
Cell|March 31, 2023
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variantsDaniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, et al.
Pageof 1